X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29) 29
endocrinology & metabolism (27) 27
female (27) 27
male (23) 23
index medicus (22) 22
adult (18) 18
middle aged (18) 18
criteria (8) 8
endocrinology (8) 8
medicine & public health (8) 8
acromegaly (7) 7
adolescent (7) 7
medicine/public health, general (7) 7
metabolic diseases (7) 7
treatment outcome (7) 7
tumors (7) 7
aged (6) 6
prevalence (6) 6
young adult (6) 6
abridged index medicus (5) 5
adenomas (5) 5
diagnosis (5) 5
follow-up studies (5) 5
gigantism (5) 5
mortality (5) 5
pituitary adenoma (5) 5
pituitary neoplasms - drug therapy (5) 5
pituitary neoplasms - pathology (5) 5
retrospective studies (5) 5
surgery (5) 5
time factors (5) 5
acromegaly - surgery (4) 4
adenoma - surgery (4) 4
follow-up (4) 4
growth-hormone (4) 4
human growth hormone - deficiency (4) 4
oncology (4) 4
pituitary (4) 4
pituitary neoplasms - genetics (4) 4
remission (4) 4
risk (4) 4
risk factors (4) 4
therapy (4) 4
adenoma (3) 3
adenoma - complications (3) 3
adenoma - drug therapy (3) 3
body-mass index (3) 3
child (3) 3
child, preschool (3) 3
growth hormone (3) 3
growth-hormone deficiency (3) 3
human growth hormone - blood (3) 3
insulin-like growth factor i - metabolism (3) 3
internal medicine (3) 3
mutation (3) 3
pegvisomant (3) 3
pituitary neoplasms - surgery (3) 3
radiotherapy (3) 3
acromegaly - blood (2) 2
acromegaly - diagnosis (2) 2
acromegaly - etiology (2) 2
acromegaly - genetics (2) 2
acromegaly - metabolism (2) 2
acromegaly - pathology (2) 2
acromegaly - radiotherapy (2) 2
acromegaly - therapy (2) 2
adenoma - epidemiology (2) 2
adenoma - genetics (2) 2
adenoma - metabolism (2) 2
adenoma - pathology (2) 2
adenoma - radiotherapy (2) 2
adenoma - therapy (2) 2
adolescence (2) 2
adrenocorticotropic hormone - blood (2) 2
adults (2) 2
age factors (2) 2
analysis (2) 2
article (2) 2
bioelectrical-impedance analysis (2) 2
boy (2) 2
complications and side effects (2) 2
cure (2) 2
dopamine (2) 2
dopamine agonists - therapeutic use (2) 2
expression (2) 2
gh deficiency (2) 2
gigantism - genetics (2) 2
gigantism - pathology (2) 2
girl (2) 2
glucose tolerance test (2) 2
growth hormone-releasing hormone - secretion (2) 2
growth hormone-secreting pituitary adenoma - complications (2) 2
growth-hormone excess (2) 2
hormone (2) 2
human growth hormone - administration & dosage (2) 2
human growth hormone - therapeutic use (2) 2
hypopituitarism (2) 2
in-vitro (2) 2
inhibition (2) 2
insulin sensitivity (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1924, Biblioteca dell'Archivum Romanicum, diretta da Giulio Bertoni. Serie 1, Volume 3, 231
Book
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2017, Volume 140, Issue 8, pp. 1870 - 1880
The role of progenitor/stem cells in pituitary tumorigenesis, resistance to pharmacological treatments and tumor recurrence is still unclear. This study... 
drug resistance | dopamine | tumor stem cells | pituitary adenomas | somatostatin | NEUROENDOCRINE TUMORS | ANALOG | BROMOCRIPTINE | SCINTIGRAPHY | IN-VITRO | THERAPY | ONCOLOGY | CABERGOLINE | STEM-CELL | EXPRESSION | ADENOMAS | Neoplastic Stem Cells - drug effects | Humans | Middle Aged | Spheroids, Cellular - pathology | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - pathology | Receptors, Somatostatin - genetics | Receptors, Somatostatin - agonists | Adult | DAX-1 Orphan Nuclear Receptor - biosynthesis | Female | Dopamine Agents - administration & dosage | Spheroids, Cellular - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Gonadotropins - biosynthesis | Pituitary Neoplasms - genetics | Receptors, Dopamine D2 - agonists | Carcinogenesis - genetics | Pituitary Neoplasms - pathology | ERG1 Potassium Channel - biosynthesis | Receptors, Dopamine D2 - genetics | Carcinogenesis - drug effects | Drug Resistance, Neoplasm - genetics | Pituitary Neoplasms - drug therapy | Cyclin D3 - biosynthesis | Cyclin-Dependent Kinase Inhibitor p27 - biosynthesis | RNA Splicing Factors - biosynthesis | Neoplasm Recurrence, Local - genetics | Cell Proliferation - drug effects | Dopamine | Pituitary gland tumors | Analysis | Stem cells | Phenols | Gonadotropin | Drug resistance | Dopamine receptors | Cell proliferation | Drugs | Phenotypes | Transcription factors | Invasiveness | Brain tumors | Dopamine D3 receptors | Pituitary (anterior) | Gonadotropins | Kinases | Cyclin D3 | Pituitary | Agonists | Tumorigenesis | Inhibition | Somatostatin | Dopamine D2 receptors | Tumors
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 10/2015, Volume 22, Issue 5, pp. 745 - 757
Journal Article
Neuroendocrinology, ISSN 0028-3835, 12/2015, Volume 102, Issue 4, pp. 267 - 273
Introduction: Non-functioning pituitary adenomas (NFPA) account for about 40% of pituitary tumors. Pituitary deficiencies are present at diagnosis in 60-80% of... 
Original Paper | Hypopituitarism | Non-functioning pituitary adenoma | Hypoadrenalism | SURGERY | ADULT PATIENTS | DIAGNOSIS | GH DEFICIENCY | ANTERIOR-PITUITARY | FOLLOW-UP | NEUROSCIENCES | ENDOCRINE-SOCIETY | GROWTH-HORMONE | ENDOCRINOLOGY & METABOLISM | CLINICAL-PRACTICE GUIDELINE
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 11/2010, Volume 95, Issue 11, pp. E373 - E383
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 06/2015, Volume 22, Issue 3, pp. 353 - 367
Journal Article
Journal Article
Journal Article
Journal Article